These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 28262335

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
    Kuck LR, Byrne-Nash R, Gillis J, Bueter K, Couzens LK, Eichelberger MC, Rowlen KL.
    Vaccine; 2018 May 17; 36(21):2937-2945. PubMed ID: 29699789
    [Abstract] [Full Text] [Related]

  • 3. Determination of the potency of a cell-based seasonal quadrivalent influenza vaccine using a purified primary liquid standard.
    Takahashi H, Fujimoto T, Horikoshi F, Uotani T, Okutani M, Shimasaki N, Hamamoto I, Odagiri T, Nobusawa E.
    Biologicals; 2020 Nov 17; 68():32-39. PubMed ID: 33023810
    [Abstract] [Full Text] [Related]

  • 4. VaxArray potency assay for rapid assessment of "pandemic" influenza vaccines.
    Byrne-Nash RT, Miller DF, Bueter KM, Gillis JH, Kuck LR, Rowlen KL.
    NPJ Vaccines; 2018 Nov 17; 3():43. PubMed ID: 30323954
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of single radial immunodiffusion, SDS-PAGE and HPLC potency assays for inactivated influenza vaccines shows differences in ability to predict immunogenicity of haemagglutinin antigen.
    Engelhardt OG, Edge C, Dunleavy U, Guilfoyle K, Harvey R, Major D, Newman R, Penn R, Skeldon S, Storey C, Wheeler J, Wood J, Minor P.
    Vaccine; 2018 Jul 05; 36(29):4339-4345. PubMed ID: 29895503
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A latex agglutination assay to quantify the amount of hemagglutinin protein in adjuvanted low-dose influenza monovalent vaccines.
    Buffin S, Ikhelef N, Prudent J, Dubayle J, Nougarede N, Varenne MP, Moste C, Legastelois I.
    J Virol Methods; 2018 Jan 05; 251():46-53. PubMed ID: 29030070
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.
    Verma S, Soto J, Vasudevan A, Schmeisser F, Alvarado-Facundo E, Wang W, Weiss CD, Weir JP.
    PLoS One; 2017 Jan 05; 12(4):e0175733. PubMed ID: 28423025
    [Abstract] [Full Text] [Related]

  • 16. SPRi-based hemagglutinin quantitative assay for influenza vaccine production monitoring.
    Durous L, Julien T, Padey B, Traversier A, Rosa-Calatrava M, Blum LJ, Marquette CA, Petiot E.
    Vaccine; 2019 Mar 14; 37(12):1614-1621. PubMed ID: 30773402
    [Abstract] [Full Text] [Related]

  • 17. Trypsin pre-treatment corrects SRID over-estimation of immunologically active, pre-fusion HA caused by mixed immunoprecipitin rings.
    Wen Y, Palladino G, Xie Y, Ferrari A, Ma X, Han L, Dormitzer PR, Settembre EC.
    Vaccine; 2016 Jun 17; 34(29):3388-95. PubMed ID: 27154389
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development and applications of universal H7 subtype-specific antibodies for the analysis of influenza H7N9 vaccines.
    Gravel C, Elmgren C, Muralidharan A, Hashem AM, Jaentschke B, Xu K, Widdison J, Arnold K, Farnsworth A, Rinfret A, Van Domselaar G, Wang J, Li C, Li X.
    Vaccine; 2015 Feb 25; 33(9):1129-34. PubMed ID: 25620245
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.